A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients
NCT01740271
Recruiting
Epirubicin is a common chemotherapy medication used in the treatment of breast cancer. However, chemotherapy dosing is calculated based on people's height and weight, which may not be the most accurate way. The purpose of this study is to see if epirubicin dosing based on people's genetic profiles is better than the usual methods.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
10/01/2014
Locations: Cross Cancer Institute, Edmonton, Alberta
Conditions: Breast Neoplasms
Register for Updates